Stephen Simpson, CFA
Long only, growth at reasonable price, value, research analyst

NuVasive Running On Renewed MIS Vigor

Minimally invasive surgical approaches are not only here to stay in spinal care, they are likely to continue growing as a percentage of overall cases. That's great news for NuVasive (NASDAQ:NUVA), as is progress toward the sort of operating margins that would normally be expected of a quality med-tech company. While a failure to get clean operating margins above 20% looms as a long-term risk for this company, as does competition, the ongoing consolidation in the orthopedics space may well make that somebody else's problem. I'm always a little leery of jumping into a story that is already up 50% over the past year, but I can't rule out the potential upside as investors covet growth stories in...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details